Your browser is no longer supported. Please, upgrade your browser.
Becton, Dickinson and Company
IndexS&P 500 P/E44.68 EPS (ttm)5.62 Insider Own0.10% Shs Outstand291.10M Perf Week1.21%
Market Cap72.59B Forward P/E19.20 EPS next Y13.07 Insider Trans-1.30% Shs Float288.89M Perf Month4.52%
Income1.64B PEG3.84 EPS next Q2.44 Inst Own87.20% Short Float1.10% Perf Quarter-1.86%
Sales18.86B P/S3.85 EPS this Y-27.70% Inst Trans0.15% Short Ratio2.27 Perf Half Y-2.96%
Book/sh85.28 P/B2.94 EPS next Y1.87% ROA3.00% Target Price277.60 Perf Year-7.93%
Cash/sh13.00 P/C19.32 EPS next 5Y11.65% ROE6.70% 52W Range219.50 - 284.97 Perf YTD0.34%
Dividend3.32 P/FCF23.66 EPS past 5Y-4.10% ROI3.30% 52W High-11.89% Beta0.77
Dividend %1.32% Quick Ratio1.30 Sales past 5Y10.70% Gross Margin47.20% 52W Low14.39% ATR3.23
Employees72000 Current Ratio1.90 Sales Q/Q15.40% Oper. Margin12.00% RSI (14)61.70 Volatility1.37% 1.35%
OptionableYes Debt/Eq0.71 EPS Q/Q79.00% Profit Margin8.70% Rel Volume0.86 Prev Close249.35
ShortableYes LT Debt/Eq0.71 EarningsAug 05 BMO Payout57.10% Avg Volume1.41M Price251.08
Recom2.10 SMA201.63% SMA502.98% SMA2002.32% Volume1,204,549 Change0.69%
May-25-21Initiated Barclays Equal Weight $270
Dec-15-20Upgrade Morgan Stanley Equal-Weight → Overweight $297
Dec-15-20Downgrade Wells Fargo Overweight → Equal Weight $265
Jul-09-20Upgrade Barclays Equal Weight → Overweight $300
Jun-01-20Resumed Goldman Buy $278
Mar-05-20Initiated Citigroup Neutral $260
Feb-07-20Downgrade Raymond James Strong Buy → Outperform $283
Feb-07-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Feb-07-20Downgrade Cowen Outperform → Market Perform
Feb-06-20Downgrade Cowen Outperform → Market Perform
Jan-08-20Downgrade Barclays Overweight → Equal Weight $275
May-13-19Upgrade Barclays Equal Weight → Overweight $266
Dec-07-18Initiated Deutsche Bank Buy $280
Oct-16-18Initiated Barclays Equal Weight $278
Jun-21-18Upgrade JP Morgan Neutral → Overweight
Apr-10-18Upgrade Citigroup Neutral → Buy
Jan-19-18Resumed BofA/Merrill Buy $260
Jan-05-18Upgrade Citigroup Sell → Neutral
Jan-05-18Initiated KeyBanc Capital Mkts Overweight
Jan-03-18Initiated Evercore ISI Outperform
Jul-23-21 01:11PM  
Jul-20-21 06:55AM  
Jul-19-21 08:55AM  
Jul-16-21 04:47AM  
Jul-12-21 09:44AM  
Jul-07-21 06:55AM  
Jul-02-21 01:40PM  
Jun-30-21 06:11PM  
Jun-24-21 10:17AM  
Jun-23-21 06:55AM  
Jun-22-21 06:57AM  
Jun-17-21 04:30PM  
Jun-16-21 06:32AM  
Jun-14-21 02:17PM  
Jun-11-21 06:50AM  
Jun-10-21 06:45AM  
Jun-08-21 06:55AM  
Jun-07-21 10:29AM  
Jun-02-21 06:55AM  
May-31-21 10:45AM  
May-26-21 04:15PM  
May-25-21 06:50AM  
May-19-21 08:05AM  
May-18-21 09:08AM  
May-13-21 06:24PM  
May-11-21 01:11PM  
May-07-21 01:52AM  
May-06-21 12:53PM  
May-05-21 08:38AM  
May-03-21 12:25PM  
Apr-29-21 07:26PM  
Apr-28-21 06:50AM  
Apr-27-21 04:10PM  
Apr-26-21 06:00AM  
Apr-23-21 06:50AM  
Apr-22-21 11:58AM  
Apr-20-21 10:41AM  
Apr-19-21 12:10PM  
Apr-15-21 07:00AM  
Apr-14-21 04:01PM  
Apr-13-21 08:12PM  
Apr-09-21 09:00AM  
Apr-07-21 02:14AM  
Apr-06-21 01:07PM  
Apr-05-21 01:15PM  
Apr-01-21 06:58AM  
Mar-31-21 12:26PM  
Mar-30-21 07:24AM  
Mar-29-21 07:35AM  
Mar-26-21 02:07PM  
Mar-22-21 08:45AM  
Mar-17-21 07:00AM  
Mar-16-21 03:15PM  
Mar-10-21 09:55AM  
Mar-09-21 06:59AM  
Mar-08-21 02:06PM  
Mar-07-21 11:48PM  
Mar-06-21 11:31AM  
Mar-04-21 06:59AM  
Feb-27-21 05:05AM  
Feb-22-21 06:59AM  
Feb-14-21 04:08AM  
Feb-13-21 10:00AM  
Feb-12-21 05:25PM  
Feb-10-21 06:49AM  
Feb-08-21 10:11AM  
Feb-06-21 01:21AM  
Feb-05-21 12:00PM  
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detection, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, sharps disposal systems; infusion pumps, dedicated disposables, IV fluids, medication compounding workflow systems, automated medication dispensing, automated supply management systems, medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes care; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products and systems; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for high-throughput single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. Becton, Dickinson and Company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Lim James CExecutive Vice PresidentMay 28Sale241.683,429828,721801Jun 02 08:50 AM
Fraser ClaireDirectorMay 27Sale241.3639094,13020,607May 28 09:57 AM
Goette RolandEVP and President, EMEANov 23Option Exercise76.643,485267,09010,085Nov 24 04:52 PM
Goette RolandEVP and President, EMEANov 23Sale230.10930213,9937,994Nov 24 04:52 PM